Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Arch Neurol ; 68(10): 1290-4, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21987542

ABSTRACT

BACKGROUND: Diabetes mellitus (DM) is associated with an increased prevalence of peripheral arterial disease and medial arterial calcification (MAC), possibly related to prevalence and severity of diabetic polyneuropathy (DPN). OBJECTIVE: To assess the prevalence, risk covariates, and implication of MAC in a controlled study of healthy subjects and patients with DM. DESIGN: Masked evaluation of radiographs. SETTING: Olmsted County, Minnesota. PATIENTS: Ambulatory volunteers with DM from the Rochester Diabetic Neuropathy Study cohort (n = 260) and matched healthy subjects from the Rochester Diabetic Neuropathy Study-Healthy Subject cohort (n = 221). METHODS: Patients and controls underwent standard radiographs of distal legs and feet from January 1, 1995, through December 31, 2002. The radiographs were independently read by masked, experienced radiologists for vessel calcification. Medial arterial calcification prevalence, risk covariates, correlation with peripheral arterial disease, and implication for distal, length-dependent sensorimotor polyneuropathy (DSPN) were studied. RESULTS: Of 481 study participants, MAC was found in 66 (13.7%): 55 of 260 (21.2%) in patients with DM and 11 of 221 (5.0%) in healthy subjects (P < .001). Interrater agreement of MAC was 94.1% (κ coefficient of 0.7). Medial arterial calcification was significantly associated with DSPN (P < .001). In stepwise logistic regression analysis, the significant risk covariates for MAC were advancing age, male sex, DM, and stage of microvessel disease (retinopathy). CONCLUSIONS: Medial arterial calcification of legs was approximately 4 times as prevalent in population-representative ambulatory persons with DM as in healthy subjects. Advancing age, male sex, DM, and retinopathy were the significant risk covariates for MAC of legs. Medial arterial calcification of legs, although significantly associated with DSPN, was not a useful surrogate marker of DSPN. Also, MAC was not shown to be a risk covariate for late worsening of DSPN, although other lines of evidence suggest that peripheral arterial disease may worsen DSPN.


Subject(s)
Arteries/physiopathology , Diabetic Neuropathies/complications , Diabetic Neuropathies/pathology , Leg/pathology , Vascular Calcification/etiology , Adult , Aged , Case-Control Studies , Cohort Studies , Diabetic Neuropathies/epidemiology , Female , Glycemic Index , Humans , Logistic Models , Male , Middle Aged , Minnesota/epidemiology , Predictive Value of Tests , Prevalence , Risk Factors , Vascular Calcification/epidemiology
2.
Am J Surg Pathol ; 31(8): 1265-8, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17667552

ABSTRACT

We describe the clinical, radiologic, and pathologic features of 26 osteoblastomas with a multinodular growth pattern (defined as multiple nidi in a single tumor) and primarily epithelioid-appearing cells. Clinical information and histologic slides for all 26 patients and radiologic studies for 9 were examined. Follow-up information was obtained from medical charts at our institution and from correspondence with pathologists who submitted cases in consultation. Of the 23 patients with osteoblastoma whose sex had been recorded, 18 were male and 5 were female (median age, 17.8 y). The most common site was the jawbones, although long bones were also involved. Radiologic studies suggested a benign lesion in 5 patients, a malignant lesion in 2, and indeterminate features in 2. Histologically, the tumors appeared to be multiple nodules of epithelioid cells, most with a lacy, blue-bone matrix. Frequently, there were sheets of cells with no matrix. Follow-up information was obtained for 14 of the 23 patients. One patient died in an automobile accident; all others were alive as long as 29 years after treatment. Epithelioid osteoblastomas mimic osteosarcoma because of similar cellularity and cytologic features. Although follow-up is limited, we are cautiously optimistic that these are benign lesions.


Subject(s)
Bone Neoplasms/pathology , Epithelioid Cells/pathology , Osteoblastoma/pathology , Osteoblasts/pathology , Adolescent , Adult , Bone Neoplasms/surgery , Child , Child, Preschool , Curettage , Disease-Free Survival , Female , Follow-Up Studies , Humans , Male , Osteoblastoma/diagnostic imaging , Osteoblastoma/surgery , Radiography
3.
Arch Pathol Lab Med ; 131(6): 942-6, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17550323

ABSTRACT

CONTEXT: Sarcomatous transformation is a rare complication of Paget disease of bone. Prognosis in patients with other types of sarcomas arising in bone has improved in the last several decades because of therapeutic advances. However, because of the rarity of Paget sarcoma, outcome studies in these patients are limited. OBJECTIVE: To determine whether prognosis for Paget sarcoma has improved. DESIGN: Seventy cases of sarcomas arising in the setting of Paget disease were collected, and the histologic and clinical findings were reviewed. Clinical follow-up was obtained in 67 cases. RESULTS: Sarcoma arising in Paget disease tended to arise in older men (46 men, 24 women; age range, 31-88 years; mean age, 66 years) and predominated in the axial skeleton (n = 37), especially in the pelvis. Thirty-three patients had a clinical history of Paget disease ranging in duration from 16 months to 30 years (mean, 15 years). No significant difference in incidence between monostotic (n = 33) and polyostotic (n = 36) disease was noted. Most tumors were osteosarcomas (88%). All tumors were high grade. Follow-up information was obtained in 67 of 70 cases (range of follow-up, 1-252 months). Survival ranged from 1 month to 20 years, with a 5-year survival rate of 10%. CONCLUSIONS: Prognosis remains poor in patients with Paget sarcoma. There is no significant correlation between the number of bones involved with Paget disease or the duration of disease and development of Paget sarcoma. Poor prognosis in Paget sarcoma is unrelated to site or stage at presentation.


Subject(s)
Bone Neoplasms/pathology , Osteitis Deformans/pathology , Osteosarcoma/pathology , Adult , Aged , Aged, 80 and over , Bone Neoplasms/mortality , Bone Neoplasms/therapy , Combined Modality Therapy , Comorbidity , Female , Humans , Male , Middle Aged , Osteitis Deformans/mortality , Osteitis Deformans/therapy , Osteosarcoma/mortality , Osteosarcoma/therapy , Prognosis , Retrospective Studies , Survival Rate
4.
Arthritis Rheum ; 50(1): 43-54, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14730598

ABSTRACT

OBJECTIVE: To identify prognostic markers that are predictive of progressive erosive disease in patients with early rheumatoid arthritis (RA). METHODS: The study involved an inception cohort of 111 consecutive patients with RA and a disease duration of <1 year. Patients were treated according to an algorithm designed to avoid overtreatment of mild disease and to accelerate treatment in patients who had continuous disease activity. Patients were evaluated for the presence of clinical and laboratory disease activity markers. We determined the frequency of CD4+,CD28(null) T cells by flow cytometry, HLA-DRB1 gene polymorphisms by polymerase chain reaction (PCR)/sequencing, and 26 single-nucleotide polymorphisms in 19 candidate genes by multiplex PCR and hybridization to an immobilized probe array. Data were analyzed using proportional odds models to identify prognostic markers predictive of erosive progression over 2 years on serial hand/wrist radiographs. RESULTS: After 2 years, disease activity in 52% of the cohort was controlled by treatment with hydroxychloroquine and nonsteroidal agents. Forty-eight percent of the patients did not develop erosions. Older age, presence of erosions at baseline, presence of rheumatoid factor, rheumatoid factor titer, and HLA-DRB1*04 alleles, particularly homozygosity for HLA-DRB1*04, were univariate predictors of radiographic progression. Promising novel markers were the frequency of CD4+,CD28(null) T cells as an immunosenescence indicator, and a polymorphism in the uteroglobin gene. CONCLUSION: Clinical disease activity in patients with early RA can frequently be controlled with nonaggressive treatment, but this is not always sufficient to prevent new erosions. Rheumatoid factor titer, HLA-DRB1 polymorphisms, age, and immunosenescence markers are predictors of poor radiographic outcome. A polymorphism in the uteroglobin gene may identify patients who have a low risk of erosive disease.


Subject(s)
Arthritis, Rheumatoid/diagnostic imaging , Arthritis, Rheumatoid/immunology , Adolescent , Adult , Aged , Algorithms , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/genetics , Biomarkers , Disease Progression , Early Diagnosis , Female , HLA-DR Antigens/genetics , HLA-DRB1 Chains , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Predictive Value of Tests , Prognosis , Prospective Studies , Radiography , Rheumatoid Factor/blood , T-Lymphocytes/immunology , Wrist Joint/diagnostic imaging
5.
Skeletal Radiol ; 32(12): 687-94, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14530882

ABSTRACT

OBJECTIVE: To describe the radiographic features of clear cell chondrosarcoma (CCCS), including the computed tomographic (CT) and magnetic resonance (MR) findings, and to correlate them with the histopathologic findings. DESIGN AND PATIENTS: A retrospective review was carried out of 72 patients with histopathologically confirmed CCCS. Imaging studies were available for 34 patients: conventional radiographs (n=28), CT scans (n=14), and MR images (n=15). Radiographic studies were reviewed by three radiologists who rendered a consensus opinion; the studies were correlated with the histopathologic findings. RESULTS: Of the 34 patients with imaging studies, 30 were male and 4 were female (mean age 38.6 years; range 11-74 years). Twenty-two lesions were in long bones (15, proximal femur; 1, distal femur; 1, proximal tibia; 5, proximal humerus) and 11 were in flat bones (5, vertebra; 4, rib; 1, scapula; 1, innominate). One lesion occurred in the tarsal navicular bone. Typically, long bone lesions were located in the epimetaphysis (19/22) and were lucent with a well-defined sclerotic margin and no cortical destruction or periosteal new bone formation. More than one-third of the long bone lesions contained matrix mineralization with a characteristic chondroid appearance. Pathologic fractures were present in six long bone lesions (4, humerus; 2, femur). Lesions in the proximal humerus were more likely to have indistinct margins (4/5) and extend into the diaphysis. Flat bone lesions were typically lytic and expansile and occasionally demonstrated areas of cortical disruption. Typically, matrix mineralization, when present, was amorphous. MR imaging, when available, was superior to conventional radiographs for demonstrating the intramedullary extent of a lesion as well as soft tissue extension. CT images better delineated the presence of cortical destruction and the character of matrix mineralization patterns. CCCS lesions were typically low signal intensity on T1-weighted images and moderately or significantly bright on T2-weighted images. Areas of lesion heterogeneity on T1- and T2-weighted images and on post-gadolinium T1-weighted images corresponded pathologically to areas of mineralization, intralesional hemorrhage, and cystic changes. Adjacent bone marrow edema was typically absent (12/15) or only minimally observed in a few cases (3/15). No cases examined with MR imaging demonstrated periosteal new bone formation. CONCLUSIONS: CCCS typically presents radiographically as a geographic lytic lesion located in the epimetaphyseal region of long bones. Most commonly lesions are found in the proximal femur, followed by the proximal humerus. Lesions within the proximal humerus may exhibit more aggressive features. Lesions in the axial skeleton are typically expansile and destructive, often with soft tissue extension and lack of mineralization. MR imaging may show the presence or absence of bone marrow edema.


Subject(s)
Bone Neoplasms/diagnostic imaging , Bone Neoplasms/pathology , Chondrosarcoma/diagnostic imaging , Chondrosarcoma/pathology , Sarcoma, Clear Cell/diagnostic imaging , Sarcoma, Clear Cell/pathology , Adolescent , Adult , Aged , Bone Cysts, Aneurysmal/diagnostic imaging , Bone Cysts, Aneurysmal/pathology , Bone Neoplasms/classification , Calcification, Physiologic , Child , Chondrosarcoma/classification , Diagnosis, Differential , Epiphyses/diagnostic imaging , Epiphyses/pathology , Female , Femur/diagnostic imaging , Femur/pathology , Humans , Humerus/diagnostic imaging , Humerus/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Osteolysis/diagnostic imaging , Osteolysis/pathology , Retrospective Studies , Ribs/diagnostic imaging , Ribs/pathology , Sarcoma, Clear Cell/classification , Scapula/diagnostic imaging , Scapula/pathology , Severity of Illness Index , Spine/diagnostic imaging , Spine/pathology , Statistics as Topic , Tarsal Bones/diagnostic imaging , Tarsal Bones/pathology , Tibia/diagnostic imaging , Tibia/pathology , Tomography, X-Ray Computed
6.
SELECTION OF CITATIONS
SEARCH DETAIL
...